FDPS Antikörper (AA 1-419)
-
- Target Alle FDPS Antikörper anzeigen
- FDPS (Farnesyl Diphosphate Synthase (FDPS))
-
Bindungsspezifität
- AA 1-419
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FDPS Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Farnesyl pyrophosphate synthase protein (1-419AA)
- Isotyp
- IgG
- Top Product
- Discover our top product FDPS Primärantikörper
-
anti-Farnesyl Diphosphate Synthase (FDPS) antibody
FDPS Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 82-112), (N-Term) antibodyFDPS Reaktivität: Human WB, IHC (p), IF Wirt: Kaninchen Polyclonal RB4783-4784 unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 1-419) antibodyFDPS Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 389-419) antibodyFDPS Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB04786 unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 120-419) antibodyFDPS Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) antibodyFDPS Reaktivität: Human, Ratte, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 1-419) antibodyFDPS Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) antibodyFDPS Reaktivität: Human, Maus WB Wirt: Maus Monoclonal 1049CT13-1-4 unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 1-419) antibodyFDPS Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Farnesyl Diphosphate Synthase (FDPS) (AA 320-419) antibodyFDPS Reaktivität: Human ELISA Wirt: Maus Monoclonal 3A6 unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IP:1:200-1:2000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- FDPS (Farnesyl Diphosphate Synthase (FDPS))
- Andere Bezeichnung
- FDPS (FDPS Produkte)
- Hintergrund
-
Background: Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate.
Aliases: (2E antibody, (2E,6E) farnesyl diphosphate synthase antibody, 6E)-farnesyl diphosphate synthase antibody, Dimethylallyltranstransferase antibody, Farnesyl diphosphate synthase antibody, Farnesyl diphosphate synthetase antibody, Farnesyl pyrophosphate synthase antibody, Farnesyl pyrophosphate synthetase antibody, Fdps antibody, FPP synthase antibody, FPP synthetase antibody, FPPS antibody, FPPS_HUMAN antibody, FPS antibody, Geranyltranstransferase antibody
- UniProt
- P14324
- Pathways
- Regulation of Muscle Cell Differentiation
-
